Impact numbers in health policy decisions

Journal of Epidemiology and Community Health

Volumn 56, Issue 8, 2002, Pages 600-605

  Attia, J ^a   Page, J ^b   Heller, R F ^c   Dobson, A J ^d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASSESSMENT METHOD; HEALTH POLICY; PLANNING METHOD; POLICY MAKING;

ARTICLE; CONSUMER; DECISION MAKING; HEALTH CARE POLICY; METHODOLOGY; OUTCOMES RESEARCH; POPULATION SIZE; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; SAMPLING;

EID: 0036073744     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.56.8.600     Document Type: Article

References (23)

1. An assessment of clinically useful measures of the consequences of treatment
2. The number needed to treat: A clinically useful measure of treatment effect
3. Expressing the magnitude of adverse effects in case-control studies: "The number of patients needed to be treated for one additional patient to be harmed"
4. Calculating the number needed to treat for trials where the outcome is time to an event
5. Disease impact number and population impact number: Population perspectives to measures of risk and benefit
6. Impact numbers: Measures of risk factor impact on the whole population from case-control and cohort studies
7. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure
8. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
9. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
10. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
11. Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction
12. ABC of heart failure. History and epidemiology
13. Death and re-admission in the year after hospital admission with cardiovascular disease: The hunter area heart and stroke register
14. Commentary: DINS and PINS and things-clinical and population perspectives on treatment effects
15. An evidence based approach to individualising treatment
16. Benefit of screening mammography in women aged 40-49: A new meta-analysis of randomized controlled trials
17. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Haemoccult
18. Estimating the number needed to treat (NNT) index when the data are subject to error
19. Confidence intervals for the number needed to treat
20. Number needed to treat: Properties and problems
21. A population perspective to evidence based Medicine: Evidence for population health